Cargando…
miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
A miRNAs profiling on a group of familial and sporadic breast cancers showed that miRNA-342 was significantly associated with estrogen receptor (ER) levels. To investigate at functional level the role of miR-342 in the pathogenesis of breast cancer, we focused our attention on its “in silico” predic...
Autores principales: | Crippa, Elisabetta, Lusa, Lara, De Cecco, Loris, Marchesi, Edoardo, Calin, George Adrian, Radice, Paolo, Manoukian, Siranoush, Peissel, Bernard, Daidone, Maria Grazia, Gariboldi, Manuela, Pierotti, Marco Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903605/ https://www.ncbi.nlm.nih.gov/pubmed/24475217 http://dx.doi.org/10.1371/journal.pone.0087039 |
Ejemplares similares
-
miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells
por: Crippa, Elisabetta, et al.
Publicado: (2016) -
First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report
por: Ripamonti, Carla B, et al.
Publicado: (2013) -
Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations
por: Colombo, Mara, et al.
Publicado: (2013) -
Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1
por: Caleca, Laura, et al.
Publicado: (2014) -
Adherence to Mediterranean Diet and Metabolic Syndrome in
BRCA Mutation Carriers
por: Bruno, Eleonora, et al.
Publicado: (2017)